Episode 202: The Uromigos Paper of the Month—Docetaxel and Continuous Enzalutamide in CRPC

By The Uromigos - November 7, 2022

The Uromigos chat with Axel Merseburger, MD, PhD, Chairman of the Clinic of Urology at University Hospital Schleswig-Holstein in Lübeck, Germany, about his paper on continuing enzalutamide with docetaxel for the treatment of castration-resistant prostate cancer.

Post Tags:Uromigos-Prostate Cancer
Advertisement
Advertisement